Sarah Cork
Orphan Drug Exclusivity for CRISPR/Cas-Based Therapeutics
Minding Your Business ·
HHS Can’t Force Disclosure of Drug Prices in Ads with “Blunderbuss” Rule
Minding Your Business ·
Bipartisan Congress Intensifies Efforts to Restrict Orphan Drug Exclusivity
Minding Your Business ·